Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma

Acta Derm Venereol. 2020 Nov 26;100(18):adv00335. doi: 10.2340/00015555-3681.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Dermatitis*
  • Humans
  • Ipilimumab / therapeutic use
  • Melanoma* / drug therapy
  • Nivolumab / adverse effects
  • Skin Neoplasms* / drug therapy

Substances

  • Ipilimumab
  • Nivolumab